Oxon IP has been listed for the fifth consecutive year as one of Europe’s Leading Patent Law Firms in the prestigious Financial Times annual rankings. The firm was also particularly recommended for its services in the Biotechnology, Food, Healthcare, Chemistry and Pharmacy sectors.
Oxon IP was also earlier this year ranked in the Legal 500 for Intellectual Property (Patents) as a Leading Law Firm.
Oxon IP Director Leythem Wall, also listed in IAM 1000, IAM 300, MIP IP stars and a nominated practitioner of the year, says: “To be included for the fifth year running in the Financial Times rankings is a wonderful honour and achievement, as well as a testament to the sustained success of Oxon IP. All thanks go to our incredible clients and colleagues.”
The Financial Times full report on Europe’s Leading Patent Law Firms for 2026 can be found here
